<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on July 28, 2020</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT04164576</url>
  </required_header>
  <id_info>
    <org_study_id>7547</org_study_id>
    <nct_id>NCT04164576</nct_id>
  </id_info>
  <brief_title>Study of the Pathogenicity and Humoral Immune Response Induced by BK Virus in Lung Transplant Recipients</brief_title>
  <acronym>BKV-Pneumo</acronym>
  <official_title>Study of the Pathogenicity and Humoral Immune Response Induced by BK Virus in Lung Transplant Recipients</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Strasbourg, France</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Strasbourg, France</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      BK virus (BKV) is a ubiquitous virus that infects more than 80% of the population. In case of
      immunosuppression, BKV can replicate and induce nephropathies in renal transplant recipients
      or haemorrhagic cystitis in bone marrow transplant recipients. The disruption of the balance
      between BKV replication and immune control is considered the key element in the development
      of these pathologies. During lung transplantation, patients undergo intense immunosuppression
      that favors the reactivation of persistent viruses such as EBV, CMV and probably BKV.
      Although the data on EBV and CMV reactivation are very clear and allow optimal management,
      the prevalence of BKV replication and its clinical impact in lung transplant recipients
      remains unknown at this time.

      The aim of this study is to know the incidence and clinical impact of BKV replication in lung
      transplant recipients. Moreover, the results will help to better understand the interaction
      between the virus and his host, with a focus on the humoral and cellular immune response
      against BKV. The results could possibly enable to define predictive markers of BKV
      replication and of its evolution.
    </textblock>
  </brief_summary>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">January 2020</start_date>
  <completion_date type="Anticipated">June 2027</completion_date>
  <primary_completion_date type="Anticipated">January 2020</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>BKV viral load in urine (viruria) and in plasma (viremia)</measure>
    <time_frame>3 years</time_frame>
    <description>In cases of positive viral load, the viral genome will be sequenced to identify the replicative genotype.</description>
  </primary_outcome>
  <secondary_outcome>
    <measure>Quantification of anti-BKV neutralizing antibodies</measure>
    <time_frame>3 years</time_frame>
  </secondary_outcome>
  <other_outcome>
    <measure>Quantification of BKV specific T lymphocytes</measure>
    <time_frame>3 years</time_frame>
  </other_outcome>
  <other_outcome>
    <measure>TTV viral load in plasma</measure>
    <time_frame>3 years</time_frame>
    <description>Evaluation of the viral load of TTV (reflection of global immunosuppression) or its genotype (established by sequencing).</description>
  </other_outcome>
  <enrollment type="Anticipated">120</enrollment>
  <condition>Renal-urinary Impairment</condition>
  <condition>Graft Rejection</condition>
  <condition>Infection Episodes</condition>
  <intervention>
    <intervention_type>Genetic</intervention_type>
    <intervention_name>Transplant patients</intervention_name>
    <description>Study the specific immunity against Polyomavirus</description>
  </intervention>
  <biospec_retention>Samples With DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      Plasma and serum, white cells, urine, bronchoalveolar fluid, frozen and fixed tissue
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Lung transplant recipients between 30 June 2018 and 31 December 2022 at the University
        Hospital of Strasbourg
      </textblock>
    </study_pop>
    <sampling_method>Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion criteria:

          -  Lung transplant recipients in Strasbourg University Hospital between 30 June 2018 and
             31 December 2022

          -  Male or female patients, age over 18 years

          -  Patient having provided informed written consent to take part in the study

          -  Patient affiliated to Social Security

        Exclusion criteria:

          -  Patient deprived of liberty, by judicial or administrative decision

          -  Patient under legal guardianship

          -  Impossibility to give complete information about this study to the patient
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <location>
    <facility>
      <name>Les HÃ´pitaux Universitaires de Strasbourg</name>
      <address>
        <city>Strasbourg</city>
        <zip>67091</zip>
        <country>France</country>
      </address>
    </facility>
    <contact>
      <last_name>Samira FAFI-KREMER</last_name>
      <phone>+33 369551438</phone>
      <email>samira.fafi-kremer@chru-strasbourg.fr</email>
    </contact>
    <investigator>
      <last_name>Samira FAFI-KREMER</last_name>
      <role>Principal Investigator</role>
    </investigator>
    <investigator>
      <last_name>Floriane GALLAIS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Morgane SOLIS</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Romain KESSLER</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Eva CHATRON</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Tristan DEGOT</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Marianne RIOU</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Michele PORZIO</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Armelle SCHULLER</last_name>
      <role>Sub-Investigator</role>
    </investigator>
    <investigator>
      <last_name>Sandrine HIRSCHI</last_name>
      <role>Sub-Investigator</role>
    </investigator>
  </location>
  <location_countries>
    <country>France</country>
  </location_countries>
  <verification_date>November 2019</verification_date>
  <study_first_submitted>November 12, 2019</study_first_submitted>
  <study_first_submitted_qc>November 12, 2019</study_first_submitted_qc>
  <study_first_posted type="Actual">November 15, 2019</study_first_posted>
  <last_update_submitted>November 12, 2019</last_update_submitted>
  <last_update_submitted_qc>November 12, 2019</last_update_submitted_qc>
  <last_update_posted type="Actual">November 15, 2019</last_update_posted>
  <responsible_party>
    <responsible_party_type>Sponsor</responsible_party_type>
  </responsible_party>
  <keyword>Lung transplantation</keyword>
  <keyword>BKV</keyword>
  <keyword>Nephropathy</keyword>
  <keyword>Immunosuppression</keyword>
  <patient_data>
    <sharing_ipd>Undecided</sharing_ipd>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

